Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Barnes

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Thorax|July 1, 1994
Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal womenP A Cistulli, D J Barnes, R R Grunstein, et al.
Leukemia|January 26, 2007
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell linesD J Barnes, S De, P van Hensbergen, et al.
Thorax|January 22, 2008
Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturationA J Piper, D Wang, B J Yee, et al.
Respiratory Physiology & Neurobiology|March 3, 2016
Effect of non-invasive ventilation on the measurement of ventilatory and metabolic variablesC J Dennis, C Menadue, A R Harmer, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 28, 2008
Effect of water on overbased sulfonate engine oil additivesJ W Tavacoli, P J Dowding, D C Steytler, et al.
Leukemia|April 11, 2008
Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cellsE Bonhoure, A Lauret, D J Barnes, et al.
Leukemia|September 17, 2005
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cellsC Chuah, D J Barnes, M Kwok, et al.
Diabetes|October 29, 1998
Microalbuminuria and coronary heart disease in NIDDM: an incidence studyM B Mattock, D J Barnes, G Viberti, et al.
Thorax|February 14, 2009
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trialR D McEvoy, R J Pierce, D Hillman, et al.
Leukemia|June 18, 2004
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateA J Tipping, S Baluch, D J Barnes, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Thorax|July 1, 1994
Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal womenP A Cistulli, D J Barnes, R R Grunstein, et al.
Leukemia|January 26, 2007
Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell linesD J Barnes, S De, P van Hensbergen, et al.
Thorax|January 22, 2008
Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturationA J Piper, D Wang, B J Yee, et al.
Respiratory Physiology & Neurobiology|March 3, 2016
Effect of non-invasive ventilation on the measurement of ventilatory and metabolic variablesC J Dennis, C Menadue, A R Harmer, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 28, 2008
Effect of water on overbased sulfonate engine oil additivesJ W Tavacoli, P J Dowding, D C Steytler, et al.
Leukemia|April 11, 2008
Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cellsE Bonhoure, A Lauret, D J Barnes, et al.
Leukemia|September 17, 2005
Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cellsC Chuah, D J Barnes, M Kwok, et al.
Diabetes|October 29, 1998
Microalbuminuria and coronary heart disease in NIDDM: an incidence studyM B Mattock, D J Barnes, G Viberti, et al.
Thorax|February 14, 2009
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trialR D McEvoy, R J Pierce, D Hillman, et al.
Leukemia|June 18, 2004
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateA J Tipping, S Baluch, D J Barnes, et al.
Pageof 7